Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.
Chen CH, Changou CA, Hsieh TH, Lee YC, Chu CY, Hsu KC, Wang HC, Lin YC, Lo YN, Liu YR, Liou JP, Yen Y.
Chen CH, et al. Among authors: yen y.
Clin Cancer Res. 2018 Mar 1;24(5):1176-1189. doi: 10.1158/1078-0432.CCR-17-2066. Epub 2017 Dec 8.
Clin Cancer Res. 2018.
PMID: 29222162